148 related articles for article (PubMed ID: 33910978)
1. SHP2 drives inflammation-triggered insulin resistance by reshaping tissue macrophage populations.
Paccoud R; Saint-Laurent C; Piccolo E; Tajan M; Dortignac A; Pereira O; Le Gonidec S; Baba I; Gélineau A; Askia H; Branchereau M; Charpentier J; Personnaz J; Branka S; Auriau J; Deleruyelle S; Canouil M; Beton N; Salles JP; Tauber M; Weill J; Froguel P; Neel BG; Araki T; Heymes C; Burcelin R; Castan I; Valet P; Dray C; Gautier EL; Edouard T; Pradère JP; Yart A
Sci Transl Med; 2021 Apr; 13(591):. PubMed ID: 33910978
[TBL] [Abstract][Full Text] [Related]
2. Disrupting phosphatase SHP2 in macrophages protects mice from high-fat diet-induced hepatic steatosis and insulin resistance by elevating IL-18 levels.
Liu W; Yin Y; Wang M; Fan T; Zhu Y; Shen L; Peng S; Gao J; Deng G; Meng X; Kong L; Feng GS; Guo W; Xu Q; Sun Y
J Biol Chem; 2020 Jul; 295(31):10842-10856. PubMed ID: 32546483
[TBL] [Abstract][Full Text] [Related]
3. Decitabine assists umbilical cord-derived mesenchymal stem cells in improving glucose homeostasis by modulating macrophage polarization in type 2 diabetic mice.
Gao J; Cheng Y; Hao H; Yin Y; Xue J; Zhang Q; Li L; Liu J; Xie Z; Yu S; Li B; Han W; Mu Y
Stem Cell Res Ther; 2019 Aug; 10(1):259. PubMed ID: 31426846
[TBL] [Abstract][Full Text] [Related]
4. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance.
Odegaard JI; Ricardo-Gonzalez RR; Goforth MH; Morel CR; Subramanian V; Mukundan L; Red Eagle A; Vats D; Brombacher F; Ferrante AW; Chawla A
Nature; 2007 Jun; 447(7148):1116-20. PubMed ID: 17515919
[TBL] [Abstract][Full Text] [Related]
5. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
[TBL] [Abstract][Full Text] [Related]
6. MiR-130b promotes obesity associated adipose tissue inflammation and insulin resistance in diabetes mice through alleviating M2 macrophage polarization via repression of PPAR-γ.
Zhang M; Zhou Z; Wang J; Li S
Immunol Lett; 2016 Dec; 180():1-8. PubMed ID: 27746169
[TBL] [Abstract][Full Text] [Related]
7. Impact of tissue macrophage proliferation on peripheral and systemic insulin resistance in obese mice with diabetes.
Morita Y; Senokuchi T; Yamada S; Wada T; Furusho T; Matsumura T; Ishii N; Nishida S; Nishida S; Motoshima H; Komohara Y; Yamagata K; Araki E
BMJ Open Diabetes Res Care; 2020 Oct; 8(1):. PubMed ID: 33087339
[TBL] [Abstract][Full Text] [Related]
8. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity.
Heilbronn LK; Campbell LV
Curr Pharm Des; 2008; 14(12):1225-30. PubMed ID: 18473870
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin is a key player for local adipose tissue macrophage proliferation in obesity.
Tardelli M; Zeyda K; Moreno-Viedma V; Wanko B; Grün NG; Staffler G; Zeyda M; Stulnig TM
Mol Metab; 2016 Nov; 5(11):1131-1137. PubMed ID: 27818939
[TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor deficiency ameliorates high-fat diet induced insulin resistance in mice with reduced adipose inflammation and hepatic steatosis.
Finucane OM; Reynolds CM; McGillicuddy FC; Harford KA; Morrison M; Baugh J; Roche HM
PLoS One; 2014; 9(11):e113369. PubMed ID: 25412423
[TBL] [Abstract][Full Text] [Related]
11. Pancreastatin inhibitor PSTi8 protects the obesity associated skeletal muscle insulin resistance in diet induced streptozotocin-treated diabetic mice.
Gupta AP; Garg R; Singh P; Goand UK; Syed AA; Valicherla GR; Riyazuddin M; Mugale MN; Gayen JR
Eur J Pharmacol; 2020 Aug; 881():173204. PubMed ID: 32439261
[TBL] [Abstract][Full Text] [Related]
12. A novel benzenediamine derivative FC98 reduces insulin resistance in high fat diet-induced obese mice by suppression of metaflammation.
Chen C; Zhang W; Shi H; Zhuo Y; Yang G; Zhang A; Hou Y; Xiang Tan R; Li E
Eur J Pharmacol; 2015 Aug; 761():298-308. PubMed ID: 26086863
[TBL] [Abstract][Full Text] [Related]
13. FNDC5 attenuates adipose tissue inflammation and insulin resistance via AMPK-mediated macrophage polarization in obesity.
Xiong XQ; Geng Z; Zhou B; Zhang F; Han Y; Zhou YB; Wang JJ; Gao XY; Chen Q; Li YH; Kang YM; Zhu GQ
Metabolism; 2018 Jun; 83():31-41. PubMed ID: 29374559
[TBL] [Abstract][Full Text] [Related]
14. The Prostaglandin E2 Receptor EP4 Regulates Obesity-Related Inflammation and Insulin Sensitivity.
Yasui M; Tamura Y; Minami M; Higuchi S; Fujikawa R; Ikedo T; Nagata M; Arai H; Murayama T; Yokode M
PLoS One; 2015; 10(8):e0136304. PubMed ID: 26308623
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance causes inflammation in adipose tissue.
Shimobayashi M; Albert V; Woelnerhanssen B; Frei IC; Weissenberger D; Meyer-Gerspach AC; Clement N; Moes S; Colombi M; Meier JA; Swierczynska MM; Jenö P; Beglinger C; Peterli R; Hall MN
J Clin Invest; 2018 Apr; 128(4):1538-1550. PubMed ID: 29528335
[TBL] [Abstract][Full Text] [Related]
16. M2-specific reduction of CD1d switches NKT cell-mediated immune responses and triggers metaflammation in adipose tissue.
Zhang H; Xue R; Zhu S; Fu S; Chen Z; Zhou R; Tian Z; Bai L
Cell Mol Immunol; 2018 May; 15(5):506-517. PubMed ID: 28392574
[TBL] [Abstract][Full Text] [Related]
17. The Ron Receptor Tyrosine Kinase Regulates Macrophage Heterogeneity and Plays a Protective Role in Diet-Induced Obesity, Atherosclerosis, and Hepatosteatosis.
Yu S; Allen JN; Dey A; Zhang L; Balandaram G; Kennett MJ; Xia M; Xiong N; Peters JM; Patterson A; Hankey-Giblin PA
J Immunol; 2016 Jul; 197(1):256-65. PubMed ID: 27233965
[TBL] [Abstract][Full Text] [Related]
18. Unique metabolic activation of adipose tissue macrophages in obesity promotes inflammatory responses.
Boutens L; Hooiveld GJ; Dhingra S; Cramer RA; Netea MG; Stienstra R
Diabetologia; 2018 Apr; 61(4):942-953. PubMed ID: 29333574
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor 1 ameliorates adipose tissue inflammation and systemic insulin resistance via enhancing adipocyte mTORC2/Rictor signal.
Zhao L; Fan M; Zhao L; Yun H; Yang Y; Wang C; Qin D
J Cell Mol Med; 2020 Nov; 24(21):12813-12825. PubMed ID: 32979037
[TBL] [Abstract][Full Text] [Related]
20. Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance.
Nishimoto S; Fukuda D; Higashikuni Y; Tanaka K; Hirata Y; Murata C; Kim-Kaneyama JR; Sato F; Bando M; Yagi S; Soeki T; Hayashi T; Imoto I; Sakaue H; Shimabukuro M; Sata M
Sci Adv; 2016 Mar; 2(3):e1501332. PubMed ID: 27051864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
